Morgan Stanley Research Note on ARES Conversion and Share Price Valuation

Morgan Stanley Research Note on ARES Conversion and Share Price Valuation The passage is a standard equity research analysis discussing valuation metrics, price estimates, and performance of ARES and comparable firms. It contains no references to influential political actors, financial misconduct, or controversial actions, offering no actionable investigative leads. Key insights: Analyzes ARES stock performance and impact of C‑corp conversion on valuation.; Provides estimated upside/downside scenarios and multiple expansion metrics.; Compares ARES to peers such as APO, OAK, KKR, BX, and CG.